首页|乳腺癌患者血清CXCL3、TLRs9表达与术后复发转移的相关性分析

乳腺癌患者血清CXCL3、TLRs9表达与术后复发转移的相关性分析

扫码查看
目的 分析血清CXC趋化因子配体3(CXCL3)、Toll样受体9(TLRs9)与乳腺癌患者术后病情复发转移的相关性。方法 选取105 例乳腺癌患者,所有患者均接受保乳术治疗,比较入组患者治疗前后的血清肿瘤标志物水平,血清CXCL3 mRNA、TLRs9 mRNA表达情况;分析血清CXCL3 mRNA、TLRs9 mRNA与乳腺癌患者病情严重程度的相关性及对乳腺癌术后病情复发或转移的预测价值。结果 治疗后,癌胚抗原(CEA)、糖类抗原153(CA153)、糖类抗原199(CA199)水平及CXCL3 mRNA、TLRs9 mRNA的相对表达量均低于治疗前,差异有统计学意义(P<0。05)。CXCL3 mRNA、TLRs9 mRNA与CEA、CA153、CA199 正相关(P<0。05)。复发转移组CXCL3 mRNA、TLRs9 mRNA的相对表达量均高于未复发转移组(P<0。05)。CXCL3 mRNA对乳腺癌术后复发转移的预测灵敏度、特异度分别为85。25%、79。66%,截断值为0。85;TLRs9 mRNA对乳腺癌术后复发转移的预测灵敏度、特异度分别为 82。72%、75。49%,截断值为 10。71(AUC>0。85)。结论 检测血清中CXCL3 mRNA、TLRs mRNA表达水平变化或可实现对患者术后病情复发、转移风险的早期预测。
Relationship between the expression of CXCL3 and TLRs9 in serum and postoperative recurrence and metastasis of breast cancer
Objective To analyze the relationship between serum CXC recombinant chemokine ligand 3(CXCL3),Toll-like receptors 9(TLR9),and postoperative recurrence and metastasis of breast cancer.Methods 105 breast cancer patients were underwent breast-conserving surgery.Differences in the serum levels of tumor markers,serum CXCL3 mRNA,and TLs9 mRNA before and after treatment were compared.The correlation between CXCL3 mRNA and TLR9 mRNA and the severity of breast cancer was tested using the Spearman correlation coefficient.The predictive value of CXCL3 and TLR9 mRNA for recurrence or metastasis after surgery was verified by drawing the receiver operating characteristic(ROC)curve.Results Post-surgery,patients had lower levels of CEA,CA153,CA199,CXCL3,and TLR9 compared to preoperative levels,showing a statistically significant difference(P<0.05).The mRNA levels of CXCL3 and TLR9 were positively correlated with CEA,CA153,and CA199(P<0.05).The relative expression levels of CXCL3 and TLR9 mRNA,along with CEA,CA153,and CA199 in the recurrence and metastasis group,were higher than those in the non-recurrence and metastasis group(P<0.05).The ROC curve analysis showed that the sensitivity and specificity of CXCL3 mRNA in predicting postoperative recurrence and metastasis of breast cancer were 85.25%and 79.66%,respectively,and the cut-off value was 0.85.The sensitivity and specificity of TLRs 9 mRNA in predicting postoperative recurrence and metastasis of breast cahcer were 82.72%and 75.49%,respectively,and the cut-off value was 10.71(AUC>0.85).Conclusion Monitoring changes in serum levels of CXCL3 and TLR9 may enable early prediction of postoperative disease recurrence and metastasis risk in breast cancer patients.

breast cancerpostoperative metastasis and recurrenceCXC chemokine ligand 3Toll like receptor 9predictive value

韩洁琼、杨喜永

展开 >

驻马店市中心医院检验科,驻马店 463000

乳腺癌 CXC趋化因子配体3 Toll样受体9 预测价值

2024

华夏医学
桂林医学院

华夏医学

影响因子:0.569
ISSN:1008-2409
年,卷(期):2024.37(6)